Research ArticleArticle
Open Access
Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program
Michael E. Weinblatt, Larry W. Moreland, Rene Westhovens, Roger B. Cohen, Sheila M. Kelly, Nader Khan, Ramesh Pappu, Ingrid Delaet, Allison Luo, Sheila Gujrathi and Marc C. Hochberg
The Journal of Rheumatology June 2013, 40 (6) 787-797; DOI: https://doi.org/10.3899/jrheum.120906
Michael E. Weinblatt
From Brigham and Women’s Hospital, Boston, Massachusetts,
USA; University of Pennsylvania Medical Center (UPMC) Arthritis and Autoimmunity Center, Pittsburgh, Pennsylvania,
USA; Catholic University of Leuven, Leuven,
Belgium; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Bristol-Myers Squibb, Princeton, New Jersey; and University of Maryland School of Medicine, Baltimore, Maryland,
USA.
Larry W. Moreland
Rene Westhovens
Roger B. Cohen
Sheila M. Kelly
Nader Khan
Ramesh Pappu
Ingrid Delaet
Allison Luo
Sheila Gujrathi
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- Weinblatt M,
- Combe B,
- Covucci A,
- Aranda R,
- Becker JC,
- Keystone E
- 6.↵
- 7.↵
- Westhovens R,
- Robles M,
- Ximenes AC,
- Nayiager S,
- Wollenhaupt J,
- Durez P,
- et al.
- 8.↵
- Wallis RS,
- Broder MS,
- Wong JY,
- Hanson ME,
- Beenhouwer DO
- 9.↵
- 10.↵
- 11.↵
- Bongartz T,
- Sutton AJ,
- Sweeting MJ,
- Buchan I,
- Matteson EL,
- Montori V
- 12.↵
- 13.↵
- 14.↵
- Weinblatt M,
- Schiff M,
- Goldman A,
- Kremer J,
- Luggen M,
- Li T,
- et al.
- 15.↵
- Schiff M,
- Keiserman M,
- Codding C,
- Songcharoen S,
- Berman A,
- Nayiager S,
- et al.
- 16.↵
- Buch MH,
- Boyle DL,
- Rosengren S,
- Saleem B,
- Reece RJ,
- Rhodes LA,
- et al.
- 17.↵
- Schiff M,
- Pritchard C,
- Huffstutter JE,
- Rodriguez-Valverde V,
- Durez P,
- Zhou X,
- et al.
- 18.↵
- 19.↵PharMetrics Integrated Database. Danbury, CT: IMS. [Internet. Accessed February 27, 2013.] Available from: http://www.imshealth.com/portal/site/ims/menuitem.d248e29c86589c9c30e81c033208c22a/?vgnextoid=d6952a2e23264310VgnVCM100000ed152ca2RCRD&vgnextfmt=default
- 20.↵
- 21.↵
- Lawson DH,
- Sherman V,
- Hollowell J
- 22.↵
- National Cancer Institute
- 23.↵
- Simon TA,
- Smitten AL,
- Franklin J,
- Askling J,
- Lacaille D,
- Wolfe F,
- et al.
- 24.↵
- 25.↵
- Komano Y,
- Tanaka M,
- Nanki T,
- Koike R,
- Sakai R,
- Kameda H,
- et al.
- 26.↵
- 27.↵
- 28.↵
- Burmester GR,
- Mease P,
- Dijkmans BA,
- Gordon K,
- Lovell D,
- Panaccione R,
- et al.
- 29.↵
- Leombruno JP,
- Einarson TR,
- Keystone EC
- 30.↵
- Salliot C,
- Dougados M,
- Gossec L
- 31.↵
- 32.↵
- Dixon WG,
- Hyrich KL,
- Watson KD,
- Lunt M,
- Galloway J,
- Ustianowski A,
- et al.
- 33.↵
- Schiff MH,
- Burmester GR,
- Kent JD,
- Pangan AL,
- Kupper H,
- Fitzpatrick SB,
- et al.
- 34.↵
- Tubach F,
- Salmon D,
- Ravaud P,
- Allanore Y,
- Goupille P,
- Bréban M,
- et al.
- 35.↵
- 36.↵
- 37.↵
- 38.↵
- Askling J,
- Baecklund E,
- Granath F,
- Geborek P,
- Fored M,
- Backlin C,
- et al.
- 39.↵
- Abrams JR,
- Kelley SL,
- Hayes E,
- Kikuchi T,
- Brown MJ,
- Kang S,
- et al.
- 40.↵
- 41.↵
- Weinblatt ME,
- Genovese MC,
- Schiff MH,
- Westhovens R,
- Alten R,
- Delaet I,
- et al.
In this issue
The Journal of Rheumatology
Vol. 40, Issue 6
1 Jun 2013
Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program
Michael E. Weinblatt, Larry W. Moreland, Rene Westhovens, Roger B. Cohen, Sheila M. Kelly, Nader Khan, Ramesh Pappu, Ingrid Delaet, Allison Luo, Sheila Gujrathi, Marc C. Hochberg
The Journal of Rheumatology Jun 2013, 40 (6) 787-797; DOI: 10.3899/jrheum.120906
Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program
Michael E. Weinblatt, Larry W. Moreland, Rene Westhovens, Roger B. Cohen, Sheila M. Kelly, Nader Khan, Ramesh Pappu, Ingrid Delaet, Allison Luo, Sheila Gujrathi, Marc C. Hochberg
The Journal of Rheumatology Jun 2013, 40 (6) 787-797; DOI: 10.3899/jrheum.120906